Showing 61 - 80 results of 65,969 for search '(( 5 ((ppm decrease) OR (a decrease)) ) OR ((( 100 we decrease ) OR ( 5 wt decrease ))))', query time: 1.05s Refine Results
  1. 61

    Image_2_Loss of early B cell protein λ5 decreases bone mass and accelerates skeletal aging.jpeg by Mohamed Khass (695111)

    Published 2023
    “…The trabecular bone volume over total volume (BV/TV) in J<sub>H</sub><sup>-/-</sup> mice was similar to WT mice at all ages. In contrast, at six months of age and thereafter, λ5<sup>-/-</sup> and J<sub>H</sub><sup>-/-</sup>λ5<sup>-/-</sup> mice demonstrated a severe decrease in trabecular bone mass. …”
  2. 62

    Image_3_Loss of early B cell protein λ5 decreases bone mass and accelerates skeletal aging.jpg by Mohamed Khass (695111)

    Published 2022
    “…The trabecular bone volume over total volume (BV/TV) in J<sub>H</sub><sup>-/-</sup> mice was similar to WT mice at all ages. In contrast, at six months of age and thereafter, λ5<sup>-/-</sup> and J<sub>H</sub><sup>-/-</sup>λ5<sup>-/-</sup> mice demonstrated a severe decrease in trabecular bone mass. …”
  3. 63

    Image_3_Loss of early B cell protein λ5 decreases bone mass and accelerates skeletal aging.jpg by Mohamed Khass (695111)

    Published 2023
    “…The trabecular bone volume over total volume (BV/TV) in J<sub>H</sub><sup>-/-</sup> mice was similar to WT mice at all ages. In contrast, at six months of age and thereafter, λ5<sup>-/-</sup> and J<sub>H</sub><sup>-/-</sup>λ5<sup>-/-</sup> mice demonstrated a severe decrease in trabecular bone mass. …”
  4. 64

    Image_2_Loss of early B cell protein λ5 decreases bone mass and accelerates skeletal aging.jpeg by Mohamed Khass (695111)

    Published 2022
    “…The trabecular bone volume over total volume (BV/TV) in J<sub>H</sub><sup>-/-</sup> mice was similar to WT mice at all ages. In contrast, at six months of age and thereafter, λ5<sup>-/-</sup> and J<sub>H</sub><sup>-/-</sup>λ5<sup>-/-</sup> mice demonstrated a severe decrease in trabecular bone mass. …”
  5. 65
  6. 66

    Image 5_G. vaginalis increases HSV-2 infection by decreasing vaginal barrier integrity and increasing inflammation in vivo.tif by Nuzhat Rahman (16660416)

    Published 2024
    “…</p>Methods<p>Mice were inoculated with 10<sup>7</sup> CFU of the eubiotic bacteria Lactobacillus crispatus, the dysbiotic bacteria G. vaginalis, or PBS as a negative control every 48 h for ten days. On day ten, mice were inoculated with 10<sup>5</sup> PFU WT HSV-2 333 and survival, pathology, and viral titers were assessed. …”
  7. 67
  8. 68

    S5 Fig - by Cynthia Alsayyah (18452506)

    Published 2024
    “…This indicates that inhibiting the entry of citrate into mitochondria induces the same effects as inhibiting the synthesis of peroxisomal citrate (see <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3002602#pbio.3002602.g005" target="_blank">Fig 5E</a>). …”
  9. 69
  10. 70

    Decreased activity of FASII favors the cold growth of the <i>ΔcshA</i> strain. by Vanessa Khemici (814639)

    Published 2020
    “…<i>fapR</i> mRNA levels were quantified by RT-qPCR using 16S rRNA as reference gene on total RNAs extracted from <i>wt</i> strain (PR01), <i>ΔcshA</i> strain (PR01-ΔcshA), and suppressor strains <i>ΔcshA/accC</i><sup><i>M385V</i></sup> (C51), <i>ΔcshA/accC</i><sup><i>T183I</i></sup> (sup30), <i>ΔcshA/accD</i><sup><i>F253V</i></sup> (sup17), <i>ΔcshA/accD</i><sup><i>A164V</i></sup> (sup16), <i>ΔcshA/birA</i><sup><i>D320F-FsX28</i></sup> (C58), <i>ΔcshA/birA</i><sup><i>R280stop</i></sup> (sup1) and <i>ΔcshA/bioY</i><sup><i>P123R-FsX1</i></sup> (C66), all at exponential growth phase in MH medium at 25°C. n = 5 for <i>ΔcshA</i>, <i>4 for wt</i> and 3 for all others. …”
  11. 71
  12. 72
  13. 73
  14. 74
  15. 75
  16. 76
  17. 77
  18. 78

    Effects of vidarabine, V2E, V3E and V5E on AC activity in the heart of WT and AC5KO mice. by Kenji Suita (750993)

    Published 2025
    “…<p>(A) Vidarabine (Vida), V2E, V3E and V5E similarly and significantly decreased ISO (50 µmol/L)-stimulated AC activity in the WT heart in a dose-dependent manner. …”
  19. 79
  20. 80